Dean Y. Li - Jul 1, 2021 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Role
Director
Signature
/s/ Nathan Hatfield, attorney-in-fact
Stock symbol
RXRX
Transactions as of
Jul 1, 2021
Transactions value $
$0
Form type
4
Date filed
7/6/2021, 05:00 PM
Next filing
Oct 5, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXRX Class A Common Stock Award $0 +330 +0.06% $0.00 597K Jul 1, 2021 Direct F1
holding RXRX Class A Common Stock 1.42M Jul 1, 2021 By Dean Li and Ruth Li Revocable Trust
holding RXRX Class A Common Stock 450K Jul 1, 2021 By Dean Y. Li 2021 2021 Family Trust
holding RXRX Class A Common Stock 1.35M Jul 1, 2021 By Dean Y. Li 2021 2021 GRAT
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were issued pursuant to the Issuer's Outside Director Compensation Policy.